Trial intelligence / Profile preview

Evaluation of the effects of increasing tamoxifen dose in breast cancer patients

IRCT2015082323734N1Phase 2Completed

Sponsor
Isfahan University of Medical Sciences
Start
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of tamoxifen in breast cancer, sponsored by Isfahan University of Medical Sciences. Started Oct 2015; status: completed.

02

Drugs

tamoxifen
03

Conditions

breast cancer

Beyond the preview

Go deeper on IRCT2015082323734N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2015082323734N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call